Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion type Assertion NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_head.
- NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion description "[Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_provenance.
- NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion evidence source_evidence_literature NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_provenance.
- NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion SIO_000772 16762635 NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_provenance.
- NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion wasDerivedFrom befree-20150227 NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_provenance.
- NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_assertion wasGeneratedBy ECO_0000203 NP394602.RAd6NF1eYF4wAzg-9ld47lwp5r7uHBxjdGh17JiXpnDL0130_provenance.